California Woman Wins $417 Million Compensation From Johnson & Johnson In Baby Powder Cancer Suit

A California jury on Monday requested Johnson and Johnson to pay $417 million to a lady who claimed she developed ovarian tumor in the wake of using the company’s powder based products like Johnson’s Baby Powder for feminine hygiene.

Johnson & Johnson Ordered To Pay $417 Million In Lawsuit Linking Talcum Powder To Cancer

The Los Angeles Superior Court jury’s verdict in favor of California resident Eva Echeverria was the largest yet in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of its talc-based products.

“We are grateful for the jury’s verdict on this matter and that Eva Echeverria was able to have her day in court,” Mark Robinson, her lawyer, said in a statement. The verdict included $70 million in compensatory damages and $347 million in punitive damages.

It was a major setback for J&J, which faces 4,800 similar claims nationally and has been hit with over $300 million in verdicts by juries in Missouri. “We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder,” J&J said.

Echeverria’s lawsuit was the first out of hundreds of California talc cases to go to trial. The 63-year-old claimed she developed terminal ovarian cancer after decades of using J&J’s products.

Her lawyers argued J&J encouraged women to use its products despite knowing of studies linking ovarian cancer to genital talc use. J&J’s lawyers countered that studies and federal agencies have not found that talc products are carcinogenic.

The trial follows five prior ones in Missouri state court, where many lawsuits are pending. J&J lost four of those trials and, along with a talc supplier, has been hit with $307 million in verdicts. Before Monday, the largest verdict was for $110 million.

Leave a Reply

Your email address will not be published. Required fields are marked *